Literature DB >> 15449107

Specific gene suppression using antisense strategy for growth suppression of glioma.

Akira Matsuno1, Tadashi Nagashima.   

Abstract

Antisense strategy using synthetic oligodeoxynucleotides has been applied to the suppression of specific gene expression, the modulation of various gene expression, and its biological activity. Antisense strategy is applicable for the growth suppression of glioma cells. Several genes, including transforming growth factor-alpha, basic fibroblast growth factor, fibroblast growth factor receptor 1, vascular endothelial growth factor, telomerase, topoisomerase II alpha-subunit, protein kinase C-alpha, and microtubule-associated protein 1A, have been targeted by antisense strategy in glioma cells. These antisense strategies provide a potential novel antitumor therapy for gliomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449107     DOI: 10.1007/s00795-004-0251-6

Source DB:  PubMed          Journal:  Med Electron Microsc        ISSN: 0918-4287


  2 in total

1.  Treatment of hemangioma by transfection of antisense VEGF gene.

Authors:  Shengguo Shan; Guang Shan; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

2.  Gene therapy trials for the treatment of high-grade gliomas.

Authors:  Adam M Sonabend; Ilya V Ulasov; Maciej S Lesniak
Journal:  Gene Ther Mol Biol       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.